Genetic newborn screening supports early identification of a child’s critical condition, guiding to a better start in life. Large-scale evidence shows that adding next-generation sequencing (NGS) as a ...
Routine newborn screening (NBS) has transformed early disease detection. However, traditional biochemical tests limit the range of conditions that can be identified at birth. Next-generation ...
STAMFORD, Conn.--(BUSINESS WIRE)--GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced that JAMA, the Journal of the American Medical ...
Preterm babies face greater health risks from the moment they are born. Their organs, immune systems, and metabolic pathways are not fully developed, making them more vulnerable to complications.
For more than six decades, biomarker-based newborn screening has played a pivotal role in reducing infant mortality and long-term disability by enabling early detection of metabolic and endocrine ...
A committee of experts will conduct a study examining the current landscape of newborn screening (NBS) systems, processes, and research in the United States and consider sustainable adoption of ...
The United States Cystic Fibrosis Foundation released the first guideline on newborn screening for cystic fibrosis (CF), in order to improve timely detection of CF in infants from all racial and ...
The Nevada Newborn Screening Program screens all babies for serious, but often treatable, disorders. Many conditions are not easily recognizable at birth, and if left untreated, can cause serious ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results